AAAAAA
Results:
1-11
|
Results: 11
Authors:
Para, MF
Kalish, LA
Collier, AC
Pollard, RB
Kumar, PN
Mintz, L
Wallach, FR
Drew, WL
Citation: Mf. Para et al., Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions, J ACQ IMM D, 26(4), 2001, pp. 320-325
Authors:
Murphy, EL
Assmann, SF
Collier, AC
Flanigan, TP
Kumar, PN
Wallach, FR
Krubel, S
Citation: El. Murphy et al., Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998, CLIN INF D, 32(1), 2001, pp. 116-123
Authors:
Kumar, PN
Prasanna, B
Chandramouli, GVP
Citation: Pn. Kumar et al., Facile synthesis of substituted 4-hydroxy coumarinobenzothiophenes, HETEROCYC C, 7(3), 2001, pp. 271-276
Authors:
Reiner, AP
Schwartz, SM
Kumar, PN
Rosendaal, FR
Pearce, RM
Aramaki, KM
Psaty, BM
Siscovick, DS
Citation: Ap. Reiner et al., Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women, BR J HAEM, 112(3), 2001, pp. 632-636
Authors:
Frank, MB
Reiner, AP
Schwartz, SM
Kumar, PN
Pearce, RM
Arbogast, PG
Longstreth, WT
Rosendaal, FR
Psaty, BM
Siscovick, DS
Citation: Mb. Frank et al., The Kozak sequence polymorphism of platelet glycoprotein Ib alpha and riskof nonfatal myocardial infarction and nonfatal stroke in young women, BLOOD, 97(4), 2001, pp. 875-879
Authors:
Murphy, EL
Collier, AC
Kalish, LA
Assmann, SF
Para, MF
Flanigan, TP
Kumar, PN
Mintz, L
Wallach, FR
Nemo, GJ
Citation: El. Murphy et al., Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease, ANN INT MED, 135(1), 2001, pp. 17-26
Authors:
Reiner, AP
Kumar, PN
Schwartz, SM
Longstreth, WT
Pearce, RM
Rosendaal, FR
Psaty, BM
Siscovick, DS
Citation: Ap. Reiner et al., Genetic variants of platelet glycoprotein receptors and risk of stroke in young women, STROKE, 31(7), 2000, pp. 1628-1633
Authors:
Kalish, LA
Collier, AC
Flanigan, TP
Kumar, PN
Citation: La. Kalish et al., Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and womenwith advanced HIV-1 disease, J INFEC DIS, 182(2), 2000, pp. 603-606
Authors:
Kumar, PN
Sweet, DE
McDowell, JA
Symonds, W
Lou, Y
Hetherington, S
LaFon, S
Citation: Pn. Kumar et al., Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type 1-infected adults, ANTIM AG CH, 43(3), 1999, pp. 603-608
Authors:
Sloand, EM
Kumar, PN
Kim, S
Chaudhuri, A
Weichold, FF
Young, NS
Citation: Em. Sloand et al., Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo, BLOOD, 94(3), 1999, pp. 1021-1027
Authors:
Havlir, DV
Dube, MP
McCutchan, JA
Forthal, DN
Kemper, CA
Dunne, MW
Parenti, DM
Kumar, PN
White, AC
Witt, MD
Nightingale, SD
Sepkowitz, KA
MacGregor, RR
Cheeseman, SH
Citation: Dv. Havlir et al., Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS, CLIN INF D, 27(6), 1998, pp. 1369-1375
Risultati:
1-11
|